Lista de obras - Andrew D Krystal - Dominio Público Uruguay

A WASO sub-group analysis of a 6-month study of eszopiclone 3 mg.

artículo científico publicado en 2012

A comparison of rates of residual insomnia symptoms following pharmacotherapy or cognitive-behavioral therapy for major depressive disorder.

artículo científico publicado en 2007

A compendium of placebo-controlled trials of the risks/benefits of pharmacological treatments for insomnia: the empirical basis for U.S. clinical practice

scientific article published on 18 January 2009

A double-blind, placebo-controlled study of armodafinil for excessive sleepiness in patients with treated obstructive sleep apnea and comorbid depression

artículo científico

A polysomnography study of eszopiclone in elderly patients with insomnia

artículo científico publicado en 2006

A randomized proof-of-mechanism trial applying the 'fast-fail' approach to evaluating κ-opioid antagonism as a treatment for anhedonia

scientific article published on 30 March 2020

An evaluation of the efficacy and safety of eszopiclone over 12 months in patients with chronic primary insomnia

artículo científico publicado en 2005

Antidepressant and Antipsychotic Drugs

artículo científico publicado en 2010

Assessing depression symptoms in those with insomnia: an examination of the beck depression inventory second edition (BDI-II).

artículo científico publicado en 2008

Associations of a regulatory polymorphism of monoamine oxidase-A gene promoter (MAOA-uVNTR) with symptoms of depression and sleep quality

artículo científico publicado en 2007

Behavioral insomnia therapy for fibromyalgia patients: a randomized clinical trial

artículo científico publicado en 2005

Case report: Successful riluzole augmentation therapy in treatment-resistant bipolar depression following the development of rash with lamotrigine

artículo científico publicado en 2004

Comparison of diary-derived bladder and sleep measurements across OAB individuals, primary insomniacs, and healthy controls

artículo científico publicado en 2012

Comparison of polysomnographic data in age-, sex- and Axis I psychiatric diagnosis matched HIV-seropositive and HIV-seronegative insomnia patients

artículo científico publicado en 2012

Comparison of seizure duration, ictal EEG, and cognitive effects of ketamine and methohexital anesthesia with ECT.

artículo científico publicado en 2003

Daily left prefrontal repetitive transcranial magnetic stimulation in the acute treatment of major depression: clinical predictors of outcome in a multisite, randomized controlled clinical trial

artículo científico publicado en 2008

Depression and insomnia in women

artículo científico publicado en 2004

Detrusor overactivity persisting at night and preceding nocturia in patients with overactive bladder syndrome: a nocturnal cystometrogram and polysomnogram study

artículo científico publicado en 2010

Does physiological hyperarousal enhance error rates among insomnia sufferers?

artículo científico publicado en 2013

Durability of clinical benefit with transcranial magnetic stimulation (TMS) in the treatment of pharmacoresistant major depression: assessment of relapse during a 6-month, multisite, open-label study

artículo científico publicado en 2010

Effects of antipsychotic medications on sleep in schizophrenia

artículo científico publicado en 2008

Efficacy and Safety of Doxepin 1 mg and 3 mg in a 12-week Sleep Laboratory and Outpatient Trial of Elderly Subjects with Chronic Primary Insomnia.

artículo científico publicado en 2010

Efficacy and safety of doxepin 3 and 6 mg in a 35-day sleep laboratory trial in adults with chronic primary insomnia

artículo científico publicado en 2011

Eszopiclone co-administered with fluoxetine in patients with insomnia coexisting with major depressive disorder

artículo científico publicado en 2006

Eszopiclone coadministered with escitalopram in patients with insomnia and comorbid generalized anxiety disorder

artículo científico

Eszopiclone treatment for insomnia: effect size comparisons in patients with primary insomnia and insomnia with medical and psychiatric comorbidity

artículo científico publicado en 2012

Evaluation of eszopiclone discontinuation after cotherapy with fluoxetine for insomnia with coexisting depression

artículo científico publicado en 2007

Feasibility and Acceptability of Wearable Sleep Electroencephalogram Device Use in Adolescents: Observational Study

artículo científico publicado en 2020

How the circadian rhythm affects sleep, wakefulness, and overall health: background for understanding shift work disorder

artículo científico publicado en 2012

Hypnotics should be considered for the initial treatment of chronic insomnia. Pro.

artículo científico publicado en 2005

In vivo evidence of the specificity of effects of GABA(A) receptor modulating medications.

artículo científico publicado en 2010

Individualized Low-Amplitude Seizure Therapy: Minimizing Current for Electroconvulsive Therapy and Magnetic Seizure Therapy

artículo científico publicado en 2015

Insomnia in women

artículo científico publicado en 2003

Insomnia is frequent in schizophrenia and associated with night eating and obesity

artículo científico publicado en 2011

Introduction: Definitions, measurements, and management in insomnia.

artículo científico publicado en 2004

Is cellular energy monitoring more responsive to hypoxia than pulse oximetry?

artículo científico publicado en 2020

It is time to take a stand for medical research and against terrorism targeting medical scientists

artículo científico publicado en 2008

Left dorsolateral prefrontal transcranial magnetic stimulation (TMS): sleep factor changes during treatment in patients with pharmacoresistant major depressive disorder

artículo científico publicado en 2012

Long-term efficacy and safety of zolpidem extended-release 12.5 mg, administered 3 to 7 nights per week for 24 weeks, in patients with chronic primary insomnia: a 6-month, randomized, double-blind, placebo-controlled, parallel-group, multicenter stu

artículo científico publicado en 2008

Long-term issues in the treatment of sleep disorders

artículo científico publicado en 2007

Loop diuretics have anxiolytic effects in rat models of conditioned anxiety

artículo científico publicado en 2012

Low-Frequency Ictal EEG Activity and ECT Therapeutic Impact

artículo científico publicado en 1993

Measuring sleep quality

artículo científico publicado en 2008

Modeling slow-wave activity dynamics: does an exponentially dampened periodic function really fit a single night of normal human sleep?

artículo científico publicado en 2008

Multifactorial determinants of the neurocognitive effects of electroconvulsive therapy

artículo científico publicado en 2014

NREM sleep EEG frequency spectral correlates of sleep complaints in primary insomnia subtypes.

artículo científico publicado en 2002

Novel sublingual low-dose zolpidem tablet reduces latency to sleep onset following spontaneous middle-of-the-night awakening in insomnia in a randomized, double-blind, placebo-controlled, outpatient study

artículo científico publicado en 2013

Obstructive sleep apnea and delirium: exploring possible mechanisms

artículo científico publicado en 2013

Obstructive sleep apnea and incidence of postoperative delirium after elective knee replacement in the nondemented elderly

artículo científico publicado en 2012

Optimizing the Pharmacologic Treatment of Insomnia: Current Status and Future Horizons

artículo científico publicado en 2013

Panel discussion: changing how we think about insomnia

artículo científico publicado en 2004

Pharmacological advances in the treatment of insomnia

scientific article published on January 2011

Psychiatric disorders and sleep

artículo científico publicado en 2012

Psychotic disorder in a patient with central and extrapontine myelinolysis

Repetitive transcranial magnetic stimulation of the superior frontal gyrus modulates craving for cigarettes

artículo científico publicado en 2011

Report of two cases where sleep related eating behavior occurred with the extended-release formulation but not the immediate-release formulation of a sedative-hypnotic agent.

artículo científico publicado en 2008

Review of the histamine system and the clinical effects of H1 antagonists: basis for a new model for understanding the effects of insomnia medications

artículo científico publicado en 2013

Selective kappa-opioid antagonism ameliorates anhedonic behavior: evidence from the Fast-fail Trial in Mood and Anxiety Spectrum Disorders (FAST-MAS)

artículo científico publicado en 2020

Shift work disorder case studies: applying management principles in clinical practice

artículo científico publicado en 2012

Should we be anxious when assessing anxiety using the Beck Anxiety Inventory in clinical insomnia patients?

artículo científico publicado en 2011

Sleep and psychiatric disorders: future directions

artículo científico publicado en 2006

Sleep and residual sedation after administration of zaleplon, zolpidem, and placebo during experimental middle-of-the-night awakening.

artículo científico publicado en 2006

Sleep disturbance in psychiatric disorders: effects on function and quality of life in mood disorders, alcoholism, and schizophrenia

artículo científico publicado en 2008

Sleep quality varies as a function of 5-HTTLPR genotype and stress

artículo científico publicado en 2007

Sleep-wake functioning along the cancer continuum: focus group results from the Patient-Reported Outcomes Measurement Information System (PROMIS(®))

artículo científico publicado en 2010

Subtyping primary insomnia: is sleep state misperception a distinct clinical entity?

artículo científico publicado en 2003

Sustained efficacy of eszopiclone over 6 months of nightly treatment: results of a randomized, double-blind, placebo-controlled study in adults with chronic insomnia

artículo científico publicado en 2003

Testing the reliability and validity of DSM-IV-TR and ICSD-2 insomnia diagnoses. Results of a multitrait-multimethod analysis

artículo científico publicado en 2011

The association of fatigue with depression and insomnia in HIV-seropositive patients: a pilot study

artículo científico publicado en 2011

The changing perspective on chronic insomnia management.

artículo científico publicado en 2004

The consensus sleep diary: standardizing prospective sleep self-monitoring

artículo científico publicado en 2012

The effect of insomnia definitions, terminology, and classifications on clinical practice

artículo científico publicado en 2005

The effect of vestibular stimulation in a four-hour sleep phase advance model of transient insomnia ⬇️

artículo científico publicado el 15 de agosto de 2010

The pharmacologic management of insomnia in patients with HIV.

artículo científico publicado en 2009

The possibility of preventing functional impairment due to sleep loss by pharmacologically enhancing sleep.

artículo científico publicado en 2005

The relationship of sleep with temperature and metabolic rate in a hibernating primate

artículo científico publicado en 2013

The treatment of primary insomnia.

artículo científico publicado en 2009

The use of prazosin for the treatment of trauma nightmares and sleep disturbance in combat veterans with post-traumatic stress disorder

artículo científico publicado en 2007

Tiagabine increases slow-wave sleep in a dose-dependent fashion without affecting traditional efficacy measures in adults with primary insomnia.

artículo científico publicado en 2006

Treatment of insomnia in depressed insomniacs: effects on health-related quality of life, objective and self-reported sleep, and depression ⬇️

artículo científico publicado el 15 de agosto de 2010

Using difficulty resuming sleep to define nocturnal awakenings

artículo científico publicado en 2010

Lista de obras de Andrew D Krystal

A WASO sub-group analysis of a 6-month study of eszopiclone 3 mg.

A comparison of rates of residual insomnia symptoms following pharmacotherapy or cognitive-behavioral therapy for major depressive disorder.

A compendium of placebo-controlled trials of the risks/benefits of pharmacological treatments for insomnia: the empirical basis for U.S. clinical practice

A double-blind, placebo-controlled study of armodafinil for excessive sleepiness in patients with treated obstructive sleep apnea and comorbid depression

A polysomnography study of eszopiclone in elderly patients with insomnia

A randomized proof-of-mechanism trial applying the 'fast-fail' approach to evaluating κ-opioid antagonism as a treatment for anhedonia

An evaluation of the efficacy and safety of eszopiclone over 12 months in patients with chronic primary insomnia

Antidepressant and Antipsychotic Drugs

Assessing depression symptoms in those with insomnia: an examination of the beck depression inventory second edition (BDI-II).

Associations of a regulatory polymorphism of monoamine oxidase-A gene promoter (MAOA-uVNTR) with symptoms of depression and sleep quality

Behavioral insomnia therapy for fibromyalgia patients: a randomized clinical trial

Case report: Successful riluzole augmentation therapy in treatment-resistant bipolar depression following the development of rash with lamotrigine

Comparison of diary-derived bladder and sleep measurements across OAB individuals, primary insomniacs, and healthy controls

Comparison of polysomnographic data in age-, sex- and Axis I psychiatric diagnosis matched HIV-seropositive and HIV-seronegative insomnia patients

Comparison of seizure duration, ictal EEG, and cognitive effects of ketamine and methohexital anesthesia with ECT.

Daily left prefrontal repetitive transcranial magnetic stimulation in the acute treatment of major depression: clinical predictors of outcome in a multisite, randomized controlled clinical trial

Depression and insomnia in women

Detrusor overactivity persisting at night and preceding nocturia in patients with overactive bladder syndrome: a nocturnal cystometrogram and polysomnogram study

Does physiological hyperarousal enhance error rates among insomnia sufferers?

Durability of clinical benefit with transcranial magnetic stimulation (TMS) in the treatment of pharmacoresistant major depression: assessment of relapse during a 6-month, multisite, open-label study

Effects of antipsychotic medications on sleep in schizophrenia

Efficacy and Safety of Doxepin 1 mg and 3 mg in a 12-week Sleep Laboratory and Outpatient Trial of Elderly Subjects with Chronic Primary Insomnia.

Efficacy and safety of doxepin 3 and 6 mg in a 35-day sleep laboratory trial in adults with chronic primary insomnia

Eszopiclone co-administered with fluoxetine in patients with insomnia coexisting with major depressive disorder

Eszopiclone coadministered with escitalopram in patients with insomnia and comorbid generalized anxiety disorder

Eszopiclone treatment for insomnia: effect size comparisons in patients with primary insomnia and insomnia with medical and psychiatric comorbidity

Evaluation of eszopiclone discontinuation after cotherapy with fluoxetine for insomnia with coexisting depression

Feasibility and Acceptability of Wearable Sleep Electroencephalogram Device Use in Adolescents: Observational Study

How the circadian rhythm affects sleep, wakefulness, and overall health: background for understanding shift work disorder

Hypnotics should be considered for the initial treatment of chronic insomnia. Pro.

In vivo evidence of the specificity of effects of GABA(A) receptor modulating medications.

Individualized Low-Amplitude Seizure Therapy: Minimizing Current for Electroconvulsive Therapy and Magnetic Seizure Therapy

Insomnia in women

Insomnia is frequent in schizophrenia and associated with night eating and obesity

Introduction: Definitions, measurements, and management in insomnia.

Is cellular energy monitoring more responsive to hypoxia than pulse oximetry?

It is time to take a stand for medical research and against terrorism targeting medical scientists

Left dorsolateral prefrontal transcranial magnetic stimulation (TMS): sleep factor changes during treatment in patients with pharmacoresistant major depressive disorder

Long-term efficacy and safety of zolpidem extended-release 12.5 mg, administered 3 to 7 nights per week for 24 weeks, in patients with chronic primary insomnia: a 6-month, randomized, double-blind, placebo-controlled, parallel-group, multicenter stu

Long-term issues in the treatment of sleep disorders

Loop diuretics have anxiolytic effects in rat models of conditioned anxiety

Low-Frequency Ictal EEG Activity and ECT Therapeutic Impact

Measuring sleep quality

Modeling slow-wave activity dynamics: does an exponentially dampened periodic function really fit a single night of normal human sleep?

Multifactorial determinants of the neurocognitive effects of electroconvulsive therapy

NREM sleep EEG frequency spectral correlates of sleep complaints in primary insomnia subtypes.

Novel sublingual low-dose zolpidem tablet reduces latency to sleep onset following spontaneous middle-of-the-night awakening in insomnia in a randomized, double-blind, placebo-controlled, outpatient study

Obstructive sleep apnea and delirium: exploring possible mechanisms

Obstructive sleep apnea and incidence of postoperative delirium after elective knee replacement in the nondemented elderly

Optimizing the Pharmacologic Treatment of Insomnia: Current Status and Future Horizons

Panel discussion: changing how we think about insomnia

Pharmacological advances in the treatment of insomnia

Psychiatric disorders and sleep

Psychotic disorder in a patient with central and extrapontine myelinolysis

Repetitive transcranial magnetic stimulation of the superior frontal gyrus modulates craving for cigarettes

Report of two cases where sleep related eating behavior occurred with the extended-release formulation but not the immediate-release formulation of a sedative-hypnotic agent.

Review of the histamine system and the clinical effects of H1 antagonists: basis for a new model for understanding the effects of insomnia medications

Selective kappa-opioid antagonism ameliorates anhedonic behavior: evidence from the Fast-fail Trial in Mood and Anxiety Spectrum Disorders (FAST-MAS)

Shift work disorder case studies: applying management principles in clinical practice

Should we be anxious when assessing anxiety using the Beck Anxiety Inventory in clinical insomnia patients?

Sleep and psychiatric disorders: future directions

Sleep and residual sedation after administration of zaleplon, zolpidem, and placebo during experimental middle-of-the-night awakening.

Sleep disturbance in psychiatric disorders: effects on function and quality of life in mood disorders, alcoholism, and schizophrenia

Sleep quality varies as a function of 5-HTTLPR genotype and stress

Sleep-wake functioning along the cancer continuum: focus group results from the Patient-Reported Outcomes Measurement Information System (PROMIS(®))

Subtyping primary insomnia: is sleep state misperception a distinct clinical entity?

Sustained efficacy of eszopiclone over 6 months of nightly treatment: results of a randomized, double-blind, placebo-controlled study in adults with chronic insomnia

Testing the reliability and validity of DSM-IV-TR and ICSD-2 insomnia diagnoses. Results of a multitrait-multimethod analysis

The association of fatigue with depression and insomnia in HIV-seropositive patients: a pilot study

The changing perspective on chronic insomnia management.

The consensus sleep diary: standardizing prospective sleep self-monitoring

The effect of insomnia definitions, terminology, and classifications on clinical practice

The effect of vestibular stimulation in a four-hour sleep phase advance model of transient insomnia ⬇️

The pharmacologic management of insomnia in patients with HIV.

The possibility of preventing functional impairment due to sleep loss by pharmacologically enhancing sleep.

The relationship of sleep with temperature and metabolic rate in a hibernating primate

The treatment of primary insomnia.

The use of prazosin for the treatment of trauma nightmares and sleep disturbance in combat veterans with post-traumatic stress disorder

Tiagabine increases slow-wave sleep in a dose-dependent fashion without affecting traditional efficacy measures in adults with primary insomnia.